• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性低级别尿路上皮性乳头状肿瘤。在 DAXX 免疫组织化学染色的组织切片中通过定量分析检测到细微的结构紊乱。

Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections.

机构信息

Department of Industrial Engineering and Mathematical Sciences (DIISM), Polytechnic University of the Marche Region, Ancona 60020, Italy.

Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, Ancona 60020, Italy.

出版信息

Hum Pathol. 2014 Apr;45(4):745-52. doi: 10.1016/j.humpath.2013.10.034. Epub 2013 Nov 15.

DOI:10.1016/j.humpath.2013.10.034
PMID:24565208
Abstract

The aim of the study was to identify subtle changes in the so-called architectural predominant order in nonrecurrent and recurrent papillary urothelial neoplasm of low malignant potential (PUNLMP). Quantitative analysis was performed with a software package written in LabVIEW (National Instruments, Austin, TX) in DAXX-immunostained tissue sections. Twelve cases of PUNLMP with papillary fronds sectioned lengthwise through the core were investigated and subdivided as follows: 7 nonrecurrent and 5 recurrent PUNLMP cases. Six cases of normal urothelium (NU) were included. When an epithelial thickness threshold is set at 108 μm (ie, 400 pixels), there is a complete separation between NU and PUNLMP; however, nonrecurrent and recurrent cases fall in the same range of thickness. In setting a nuclear elongation factor threshold at 2.1, there are differences between the 2 PUNLMP groups, recurrent PUNLMP and NU cases, showing a somewhat similar proportion of elongated nuclei. The nuclear orientation separates nonrecurrent from recurrent PUNLMP groups; however, NU cases do not appear as a separate group from the 2 PUNLMP groups. In combining epithelial thickness, nuclear elongation, and orientation in a multivariate analysis, the 2 PUNLMP groups appear separate between them and from NU. NU is less thickened than the 2 PUNLMP groups and shows a combination of elongated and less elongated nuclei. Elongated nuclei are more numerous in nonrecurrent PUNLMP, whereas the nuclei in recurrent PUNLMP are less elongated and less polarized than in the other group. Such finding can be used routinely to identify those PUNLMP patients who will have recurrence.

摘要

本研究旨在识别低恶性潜能非复发性和复发性乳头状尿路上皮肿瘤(PUNLMP)中所谓的建筑优势顺序的细微变化。使用在 LabVIEW(National Instruments,Austin,TX)中编写的软件包对 DAXX 免疫染色组织切片进行定量分析。研究了 12 例纵向切开乳头状叶的 PUNLMP 病例,并分为以下几类:7 例非复发性和 5 例复发性 PUNLMP 病例。纳入 6 例正常尿路上皮(NU)病例。当上皮厚度阈值设置为 108 μm(即 400 像素)时,NU 和 PUNLMP 之间有完全分离;然而,非复发性和复发性病例的厚度落在相同范围内。当核伸长因子阈值设置为 2.1 时,在 2 组 PUNLMP 中,复发性 PUNLMP 和 NU 病例之间存在差异,显示出相似比例的伸长核。核取向将非复发性与复发性 PUNLMP 组分开;然而,NU 病例似乎并未与 2 组 PUNLMP 分开。在多变量分析中结合上皮厚度、核伸长和取向,2 组 PUNLMP 彼此分开,与 NU 分开。NU 比 2 组 PUNLMP 薄,显示出伸长和非伸长核的组合。非复发性 PUNLMP 中伸长核的数量更多,而复发性 PUNLMP 中的核则比其他组的核伸长程度更低,极性也更低。这种发现可以常规用于识别那些会复发的 PUNLMP 患者。

相似文献

1
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections.复发性低级别尿路上皮性乳头状肿瘤。在 DAXX 免疫组织化学染色的组织切片中通过定量分析检测到细微的结构紊乱。
Hum Pathol. 2014 Apr;45(4):745-52. doi: 10.1016/j.humpath.2013.10.034. Epub 2013 Nov 15.
2
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.成纤维细胞生长因子受体3的强免疫组化表达、细胞角蛋白20的浅表染色模式以及低增殖活性可确定那些不会复发的低恶性潜能乳头状尿路上皮肿瘤。
Cancer. 2008 Feb 1;112(3):636-44. doi: 10.1002/cncr.23212.
3
Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential.低恶性潜能乳头状尿路上皮肿瘤中全基因组DNA甲基化和组蛋白乙酰化的免疫组织化学评估
Int J Immunopathol Pharmacol. 2008 Jul-Sep;21(3):615-23. doi: 10.1177/039463200802100315.
4
Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.全球乙酰化和甲基化变化可预测低恶性潜能的乳头状尿路上皮肿瘤的复发:定量分析。
Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):489-97. doi: 10.1177/039463201102400222.
5
Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.原发性低恶性潜能乳头状尿路上皮肿瘤(PUNLMP)的长期预后,包括具有内翻性生长的PUNLMP。
Diagn Pathol. 2015 Mar 13;10:3. doi: 10.1186/s13000-015-0234-z.
6
Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma.高级别尿路上皮癌中染色质重塑因子 DAXX 的免疫组化分析。
Diagn Pathol. 2013 Jul 2;8:111. doi: 10.1186/1746-1596-8-111.
7
Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.染色质表型核测量术可预测低恶性潜能乳头状尿路上皮肿瘤的复发。
Cell Oncol. 2007;29(1):47-58. doi: 10.1155/2007/356464.
8
Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).低恶性潜能的乳头状尿路上皮肿瘤(PUNLMP)的再评估。
Histopathology. 2020 Oct;77(4):525-535. doi: 10.1111/his.14192. Epub 2020 Sep 13.
9
Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.TERT 启动子突变在低级别尿路上皮乳头状肿瘤中的生物学意义。
Histopathology. 2018 Apr;72(5):795-803. doi: 10.1111/his.13441. Epub 2018 Jan 4.
10
Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.低度恶性潜能的乳头状尿路上皮肿瘤:诊断可靠性与预后
BJU Int. 2004 Jun;93(9):1228-31. doi: 10.1111/j.1464-410X.2004.04848.x.

引用本文的文献

1
Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers.H&E 图像的核形状和定向特征可预测早期雌激素受体阳性乳腺癌的生存情况。
Lab Invest. 2018 Nov;98(11):1438-1448. doi: 10.1038/s41374-018-0095-7. Epub 2018 Jun 29.
2
The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.组蛋白伴侣HJURP是腔面A型乳腺癌一种新的独立预后标志物。
Mol Oncol. 2015 Mar;9(3):657-74. doi: 10.1016/j.molonc.2014.11.002. Epub 2014 Nov 20.